Other Species / Isoforms
  SLC23A2 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K11-ub
IGKNTASksVEAGGS
0 7
SLC23A2 (human) IGKNTTSkSMEAGSS K11-ub
SLC23A2 (mouse) IGKNTASksVEAGGS K11-ub
SLC23A2 (rat) GVGKNTSKSVEVGGS K10
S12-p
GKNTASksVEAGGST
Upstream
0 2
Treatment
  • LPS
SLC23A2 (human) GKNTTSkSMEAGSST S12
SLC23A2 (mouse) GKNTASksVEAGGST S12-p
SLC23A2 (rat) VGKNTSKSVEVGGST S11
K22-ub
AGGSTEGkYEEEAKH
0 4
SLC23A2 (human) AGSSTEGkyEDEAKH K22-ub
SLC23A2 (mouse) AGGSTEGkYEEEAKH K22-ub
SLC23A2 (rat) VGGSTEGKYEEEAKR K21
Y23
GGSTEGkYEEEAKHS
0 1
SLC23A2 (human) GSSTEGkyEDEAKHP Y23-p
SLC23A2 (mouse) GGSTEGkYEEEAKHS Y23
SLC23A2 (rat) GGSTEGKYEEEAKRP Y22
Y60
DTELMAIYTTENGIA
0 9
SLC23A2 (human) DTELMAIyTTENGIA Y60-p
SLC23A2 (mouse) DTELMAIYTTENGIA Y60
SLC23A2 (rat) DTELMAIYTTENGIA Y59
S70-p
ENGIAEKssLAEtLD
Upstream
0 2
Treatment
  • IFN-gamma
SLC23A2 (human) ENGIAEKSSLAEtLD S70
SLC23A2 (mouse) ENGIAEKssLAEtLD S70-p
SLC23A2 (rat) ENGIAEKSSLAEtLD S69
S71-p
NGIAEKssLAEtLDs
0 1
SLC23A2 (human) NGIAEKSSLAEtLDs S71
SLC23A2 (mouse) NGIAEKssLAEtLDs S71-p
SLC23A2 (rat) NGIAEKSSLAEtLDs S70
T75-p
EKssLAEtLDstGsL
Upstream
0 12
Treatment
  • insulin
  • LPS
SLC23A2 (human) EKSSLAEtLDstGsL T75-p
SLC23A2 (mouse) EKssLAEtLDstGsL T75-p
SLC23A2 (rat) EKSSLAEtLDsTGsL T74-p
S78-p
sLAEtLDstGsLDPQ
Upstream
0 21
Treatment
  • insulin
  • LPS
  • LY294002
  • MK-2206
view more >
SLC23A2 (human) SLAEtLDstGsLDPQ S78-p
SLC23A2 (mouse) sLAEtLDstGsLDPQ S78-p
SLC23A2 (rat) SLAEtLDsTGsLDPQ S77-p
T79-p
LAEtLDstGsLDPQR
Upstream
0 11
Treatment
  • IFN-gamma
  • LPS
SLC23A2 (human) LAEtLDstGsLDPQR T79-p
SLC23A2 (mouse) LAEtLDstGsLDPQR T79-p
SLC23A2 (rat) LAEtLDsTGsLDPQR T78
S81-p
EtLDstGsLDPQRSD
Upstream
0 33
Treatment
  • IFN-gamma
  • insulin
  • LPS
  • LY294002
  • MK-2206
view more >
SLC23A2 (human) EtLDstGsLDPQRSD S81-p
SLC23A2 (mouse) EtLDstGsLDPQRSD S81-p
SLC23A2 (rat) EtLDsTGsLDPQRSD S80-p
N188-ng
SLDKWKCnTTEITVA
0 1
SLC23A2 (human) SLDKWKCNTTDVSVA N188
SLC23A2 (mouse) SLDKWKCnTTEITVA N188-ng
SLC23A2 (rat) SLDKWKCNTTEITVA N187
N196-ng
TTEITVAnGTAELLE
0 1
SLC23A2 (human) TTDVSVANGTAELLH N196
SLC23A2 (mouse) TTEITVAnGTAELLE N196-ng
SLC23A2 (rat) TTEITVANGTAELLE N195
K296-ub
KFPLPIYkSKKGWTA
0 1
SLC23A2 (human) KFPLPIYKSKKGWTA K298
SLC23A2 (mouse) KFPLPIYkSKKGWTA K296-ub
SLC23A2 (rat) KFPLPIYKSKKGWTA K295
K351
YARTDARKGVLLVAP
0 1
SLC23A2 (human) YARTDARQGVLLVAP Q353
SLC23A2 (mouse) YARTDARKGVLLVAP K351
SLC23A2 (rat) YARTDARkGVLLVAP K350-ac
S403-p
YYACARLsCAPPPPI
Upstream
Downstream
1 0
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell differentiation, altered
Kinase, in vitro:
  • PKACA (mouse)
Putative in vivo kinases:
  • PKACA (mouse)
Treatment
  • PGE2
SLC23A2 (human) YYACARLSCAPPPPI S405
SLC23A2 (mouse) YYACARLsCAPPPPI S403-p
SLC23A2 (rat) YYACARLSCAPPPPI S402
Y459-p
GSRRVIQyGAALMLG
0 1
SLC23A2 (human) GSRRVIQCGAALMLA C461
SLC23A2 (mouse) GSRRVIQyGAALMLG Y459-p
SLC23A2 (rat) GSRRVIQYGAALMLG Y458
K591
KGVSKGSKSLDGMES
0 1
SLC23A2 (human) KGVGKGNksLDGMES K593-ub
SLC23A2 (mouse) KGVSKGSKSLDGMES K591
SLC23A2 (rat) KGVSKGNKSLDGMES K590
S592
GVSKGSKSLDGMESY
0 1
SLC23A2 (human) GVGKGNksLDGMESY S594-p
SLC23A2 (mouse) GVSKGSKSLDGMESY S592
SLC23A2 (rat) GVSKGNKSLDGMESY S591
Y611
GMNIIKKYRCFSYLP
0 2
SLC23A2 (human) GMNIIKKyRCFsYLP Y613-p
SLC23A2 (mouse) GMNIIKKYRCFSYLP Y611
SLC23A2 (rat) GMNIIKKYRCFSYLP Y610
S615
IKKYRCFSYLPISPT
0 1
SLC23A2 (human) IKKyRCFsYLPISPt S617-p
SLC23A2 (mouse) IKKYRCFSYLPISPT S615
SLC23A2 (rat) IKKYRCFSYLPISPT S614
T622
SYLPISPTFAGYTWK
0 1
SLC23A2 (human) sYLPISPtFVGYtWK T624-p
SLC23A2 (mouse) SYLPISPTFAGYTWK T622
SLC23A2 (rat) SYLPISPTFAGYTWK T621
T627
SPTFAGYTWKGFGKS
0 1
SLC23A2 (human) SPtFVGYtWKGLRKS T629-p
SLC23A2 (mouse) SPTFAGYTWKGFGKS T627
SLC23A2 (rat) SPTFAGYTWKGFGKS T626
S640-p
KSENSRSsDKDsQAt
Upstream
Downstream
1 0
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell differentiation, altered
Kinase, in vitro:
  • PKACA (mouse)
Putative in vivo kinases:
  • PKACA (mouse)
Treatment
  • PGE2
SLC23A2 (human) KSDNSRSSDEDsQAt S642
SLC23A2 (mouse) KSENSRSsDKDsQAt S640-p
SLC23A2 (rat) KSENRRSSDKDSQAT S639
S644-p
SRSsDKDsQAtV___
0 6
SLC23A2 (human) SRSSDEDsQAtG___ S646-p
SLC23A2 (mouse) SRSsDKDsQAtV___ S644-p
SLC23A2 (rat) RRSSDKDSQATV___ S643
T647-p
sDKDsQAtV______
Upstream
0 4
Treatment
  • IFN-gamma
SLC23A2 (human) SDEDsQAtG______ T649-p
SLC23A2 (mouse) sDKDsQAtV______ T647-p
SLC23A2 (rat) SDKDSQATV______ T646